Foe to Ally: Oncolytic Virus‐Driven Xenorejection Ignites Potent Antitumor Immunity

QR Code

Foe to Ally: Oncolytic Virus‐Driven Xenorejection Ignites Potent Antitumor Immunity

Saved in:

Bibliographic Details
Main Authors:	Yanglin Xu, Bingcheng Chang, Wei He, Jia Liu
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	MedComm – Oncology
Online Access:	https://doi.org/10.1002/mog2.70025
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Nitric Oxide in Cancer Treatment: Ally or Foe?
by: Angelika Myśliwiec, et al.
Published: (2025-06-01)

Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer
by: Feilong Zhou, et al.
Published: (2025-09-01)

Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01)

Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation of antitumor immunity
by: Ken J Ishii, et al.
Published: (2025-07-01)

Targeted Therapy for Gliomas: the Oncolytic Virus Applications
by: Mustafa, Zulkifli, et al.
Published: (2011)

Soybean: Friend or Foe
by: Sena, Cristina M., et al.
Published: (2011)

Fire, friend and foe /
by: Parker, Bertha Morris
Published: (1959)

The study of oncolytic viruses reproduction in organ cultures of human lymphoid tumors
by: F. E. Babaeva, et al.
Published: (2019-12-01)

Specific inhibitor to KRASG12C induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy
by: David L Bartlett, et al.
Published: (2025-07-01)

Human Defensins in HIV Infection: Friends or Foes?
by: Shah, Rachna, et al.
Published: (2011)

Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01)

Allies
by: S. A. Denisentsev, et al.
Published: (2020-07-01)

The dual promise of oncolytic viruses: selective targeting and therapeutic enhancement in cancer treatment
by: Alaa A. A. Aljabali, et al.
Published: (2025-07-01)

Oncolytic virus VG161 offers new hope for refractory liver cancer
by: Jinqiu Li, et al.
Published: (2025-07-01)

Soybean Phytoestrogens – Friends or Foes?
by: Šošić-Jurjević, Branka, et al.
Published: (2011)

Synergy of oncolytic adenovirus and immune checkpoint inhibitors: transforming cancer immunotherapy paradigms
by: Chong Cheng, et al.
Published: (2025-07-01)

Zika virus has an oncolytic activity against human glioblastoma U87 cells
by: V. A. Svyatchenko, et al.
Published: (2019-01-01)

Advanced Therapy Medicines Based on Oncolytic Viruses (Part II: Development and Authorisation of IMLYGIC®)
by: E. V. Melnikova, et al.
Published: (2021-12-01)

Oncolytic viruses in cancer therapy: Exploring the mechanisms and clinical potential of mammalian and avian reoviruses
by: Yi-Ying Wu, et al.
Published: (2025-01-01)

Inflammation, Aging and Cancer: Friend or Foe?
by: Khatami, Mahin
Published: (2012)

Insects: Friend or Foe? Color and Learn!
by: Jennifer L. Gillett-Kaufman
Published: (2014-06-01)

Insects: Friend or Foe? Color and Learn!
by: Jennifer L. Gillett-Kaufman
Published: (2014-06-01)

Editorial: The microbiome in surgery - friend or foe?
by: Ann-Kathrin Lederer, et al.
Published: (2025-06-01)

Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China)
by: E. V. Melnikova, et al.
Published: (2021-10-01)

Oral oncolytic magnetotactic bacteria elicit anti-colorectal tumor immunity and reprogram microbiota metabolism
by: Aodi Jiang, et al.
Published: (2025-09-01)

The culture and language of the Foe : the people of Lake Kutubu, Southern Highlands Province, Papua New Guinea /
by: Rule, Murray
Published: (1993)

Phytochemicals and Cancer Chemoprevention: Epigenetic Friends or Foe?
by: Szic, Katarzyna Szarc vel, et al.
Published: (2011)

Melanocyte Pygmentation – Friend or Foe on the Route to Melanoma
by: Ioana, Baldea
Published: (2011)

Teach Aquaculture Curriculum: Chlorine--Friend or Foe?
by: Carlos V. Martinez, et al.
Published: (2010-07-01)

Teach Aquaculture Curriculum: Chlorine--Friend or Foe?
by: Carlos V. Martinez, et al.
Published: (2010-07-01)

SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
by: T. S. Nepomnyashchikh, et al.
Published: (2019-05-01)

Therapy gone viral: Exploring the use of oncolytic viruses in non-small cell lung cancer immunotherapy
by: Jemima Steele, et al.
Published: (2025-01-01)

ISG15 as a Potent Immune Adjuvant in MVA-Based Vaccines Against Zika Virus and SARS-CoV-2
by: Juan García-Arriaza, et al.
Published: (2025-06-01)

Will digital trade be friend or foe of the green economy? Unveiling the complexities of green growth
by: Tinghui Zhang, et al.
Published: (2025-12-01)

Plasma-Assisted Ignition and Combustion
by: Starikovskiy, Andrey, et al.
Published: (2011)

VISTA immune checkpoint blunts radiotherapy-induced antitumor immune response
by: Dhanya K. Nambiar, et al.
Published: (2025-07-01)

Innate Immunity: A Potent Target for Management of Inflammatory Bowel Disease
by: Fukata, Masayuki
Published: (2012)

Spark-ignition engines : fuel injection development /
by: Fisher, Charles H.
Published: (1963)

Comparative analysis of oncolytic potential of vesicular stomatitis virus serotypes Indiana and New Jersey in cancer cell lines
by: A. S. Isaeva, et al.
Published: (2023-12-01)

Analysis of Ignition Spark Parameters Generated by Modern Ignition System in SI Engine Fueled by Ammonia
by: Mariusz Chwist, et al.
Published: (2025-07-01)